跳至主要内容
临床试验/NCT04772456
NCT04772456招募中1 期

Correlation of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging and Tumor Histopathology in Patients With Infiltrating Gliomas

University of Maryland, Baltimore1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2020年8月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
5
试验地点
1
主要终点
Accuracy of metabolic MRI to diagnose Glioma

研究概览

简要总结

The purpose of this study is to examine the safety and feasibility of performing hyperpolarized metabolic MRI in the diagnosis of brain tumor. This study will also assess the accuracy of hyperpolarized metabolic MRI to diagnose intermediate to patients with infiltrating gliomas and examine the added utility of metabolic MRI over standard MRI imaging

The FDA is allowing the use of hyperpolarized [1-13C] pyruvate (HP 13C-pyruvate) in this study.

Up to 5 patients may take part in this study at the University of Maryland, Baltimore (UMB).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Patients with a new brain lesion interpreted as suspected infiltrating gliomas including but not limited to (diffuse astrocytoma WHO grade 2; oligodendroglioma WHO grade 2 and 3; anaplastic astrocytoma WHO grade 3; astrocytoma WHO grade 4), OR, patients with prior history of infiltrating glioma scheduled for surgery for tumor biopsy or resection.
  • Ages 18-80, including male and female
  • Suitable to undergo contrast-enhanced MRI
  • Negative serum pregnancy test

排除标准

  • Inability to undergo MRI scan
  • Inability to receive IV contrast secondary to severe reaction or renal insufficiency.

研究组 & 干预措施

metabolic MRI

Experimental

Single-arm study in patients who have Glioma Perform metabolic magnetic resonance imaging on patient have a Glioma cancer to understand if metabolic MRI can be safely performed on this population

干预措施: Hyperpolarized 13C-Pyruvate (Drug)

结局指标

主要结局

Accuracy of metabolic MRI to diagnose Glioma

时间窗: Within three years post treatment

To study the accuracy of hyperpolarized metabolic MRI to diagnose Glioma Cancer. We will compare the prediction of cancer from the MRI scan compared to actual diagnosis of cancer by any subsequent workup or procedure the participant undergoes. Prediction of cancer from MRI scan will be performed by assigning a standardized score . Actual diagnosis of cancer will be based on tissue pathology.

次要结局

  • Utility of metabolic MRI over standard MRI imaging in the diagnosis of Glioma cancer(Within three years post treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dirk Mayer

Professor

University of Maryland, Baltimore

研究点 (1)

Loading locations...

相似试验